EMEA-001142-PIP02-16

Key facts

Invented name
Zerbaxa
Active substance
  • Ceftolozane
  • tazobactam
Therapeutic area
Infectious diseases
Decision number
P/0277/2017
PIP number
EMEA-001142-PIP02-16
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of pneumonia
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Tel. +31 412661521
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating